I70.211 Insurance Policy Changes

ICD-10 I70.211 is officially defined as "Atherosclerosis of native arteries of extremities with intermittent claudication, right leg." code I70.211 is referenced in 6 tracked payer policy changes from Aetna and Independence Blue Cross. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code I70.211 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Oct 23, 2026Medium impact
Actigraphy and Accelerometry (CPB 0710, reviewed 2026-10-15)
Aetna considers actigraphy testing (for example, Actiwatch) and accelerometry experimental, investigational, or unproven for listed uses, including diagnosing sleep disorders, diagnosing Alzheimer's disease, diagnosing hypertension, detecting seizures during sleep, and monitoring individuals with motor neuron diseases. CPT 95803 (actigraphy testing, minimum of 72 hours to 14 consecutive days of recording) and many listed ICD-10 codes, including those for depression, schizophrenia, Parkinson's disease and cerebral infarction, are not covered for the indications listed.
Aetna · Identified Aug 19, 2026Medium impact
Intravascular Ultrasound (CPB 0382, reviewed 2026-05-26)
Aetna's clinical policy bulletin 0382 treats intravascular ultrasound (IVUS) as medically necessary when a symptomatic member's angiogram shows 50 to 70% stenosis before an intracoronary procedure, when suspected left main coronary disease is not shown by angiography, for guidance of vena caval filter placement, for guiding and immediately assessing coronary or graft interventions, for evaluating cardiac allograft vasculopathy after heart transplant, for diagnosing and following treatment of iliac vein compression (May-Thurner) syndrome, for type B aortic dissection treated with thoracic endovascular aneurysm repair when CT is poor quality or inconclusive, and for infra-inguinal arterial disease when CO2 angiography is used because standard contrast angiography is not possible. IVUS is considered experimental, investigational, or unproven for coronary artery disease screening, for virtual histology plaque evaluation, and for other indications including carotid artery stenosis evaluation, guidance of percutaneous mechanical thrombectomy for pulmonary embolism, chronic venous obstruction stenting, and stenting of non-coronary arteries.
Aetna · Identified Aug 13, 2026Medium impact
Peripheral Vascular Rehabilitation Programs (CPB 0458, reviewed 2026-07-23)
Aetna considers medical supervision of peripheral vascular rehabilitation programs medically necessary for the treatment of persons with symptomatic peripheral artery disease (PAD), including intermittent claudication. Up to 36 sessions over a 12-week period are considered medically necessary when all of the listed supervised exercise therapy program components are met, and CPT 93668 is covered if the selection criteria are met. Medical supervision for persons with absolute contraindications to exercise and for all other indications is considered experimental, investigational, or unproven, and PADnet, the QuantaFlo System for PAD screening, and HyperView imaging are also considered experimental, investigational, or unproven or not covered for the listed indications.
Aetna · Identified Aug 13, 2026Medium impact
Peripheral Atherectomy and Thrombectomy Devices (CPB 0295, reviewed 2026-04-16)
Aetna considers peripheral atherectomy of the renal artery, visceral artery, abdominal aorta, and brachiocephalic trunk and branches experimental, investigational, or unproven because its effectiveness has not been established. The same classification applies to the BYCROSS atherectomy device for peripheral arterial disease, intravascular shockwave lithotripsy for the listed peripheral arteries, celiac artery occlusion and renal artery stenosis, and isolated segmental pharmaco-mechanical thrombolysis (Trellis Peripheral Infusion System) for deep venous thrombosis, Paget-Schroetter syndrome, and other indications. Endovascular revascularization codes CPT 37220 through 37247 and 37254 through 37299 and drug-coated balloon catheter code HCPCS C2623 are covered when selection criteria are met, and medical necessity criteria for peripheral atherectomy are set in the EviCore Healthcare Peripheral Vascular Intervention Clinical Guidelines.
Aetna · Identified Aug 12, 2026Medium impact
Actigraphy and Accelerometry (CPB 0710, reviewed 2025-10-14)
Aetna considers actigraphy testing experimental, investigational, or unproven for indications including defining lithium response dimensions in bipolar disorders, detection or screening of apnea, diagnosis of Alzheimer's disease, diagnosis of hypertension, evaluation of depression, and evaluation of schizophrenia. Aetna considers accelerometry experimental, investigational, or unproven for indications including evaluating functional ability in the elderly, differential diagnosis of tremor syndromes, gait analysis in persons with hip osteoarthritis, and monitoring of physical activity during rehabilitation of persons with stroke. CPT code 95803 (actigraphy testing, recording, analysis, interpretation and report, minimum of 72 hours to 14 consecutive days of recording) and CPT codes 0533T through 0536T (continuous recording of movement disorder symptoms) are not covered for the indications listed in the policy.
Independence Blue Cross · Identified Jun 19, 2026Low impact
MA10.008d, Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)
This is a reissue with no changes to MA10.008d. The policy confirms Independence Blue Cross's continuing position on Supervised Exercise Therapy (SET) for symptomatic Peripheral Artery Disease (PAD), covering up to 36 sessions over 12 weeks (with possible extension to 72 sessions) for Medicare Advantage members in New Jersey. No billing code changes, coverage modifications, or documentation requirements have been altered.

Watch I70.211

Get one email when a payer policy names I70.211, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code I70.211?

There are 6 tracked policy changes affecting code I70.211, including updates from Aetna, Independence Blue Cross. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code I70.211?

Payers that have issued tracked updates for code I70.211 include: Aetna, Independence Blue Cross.

How do I get notified when code I70.211 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code I70.211. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code I70.211?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Actigraphy and Accelerometry (CPB 0710, reviewed 2026-10-15)

Intravascular Ultrasound (CPB 0382, reviewed 2026-05-26)

Peripheral Vascular Rehabilitation Programs (CPB 0458, reviewed 2026-07-23)

Peripheral Atherectomy and Thrombectomy Devices (CPB 0295, reviewed 2026-04-16)

Actigraphy and Accelerometry (CPB 0710, reviewed 2025-10-14)

MA10.008d, Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)

What insurance policy changes affect code I70.211?

Which payers have updated policy for code I70.211?

How do I get notified when code I70.211 policy changes?

Why do payers change policies for code I70.211?